The Evolving Treatment Paradigm for Osteoporosis: The Integral Role of the Pharmacist in Optimizing Care, featuring a Patient Perspective

The Evolving Treatment Paradigm for Osteoporosis: The Integral Role of the Pharmacist in Optimizing Care, featuring a Patient Perspective is organized by Pharmacy Times Continuing Education (PTCE).,Release date: May 31, 2022,Expiration date: May 31, 2023,Description:,More than 2 million fractures occur each year in the United States due to osteoporosis. Increasing age and female sex are significant risk factors for developing osteoporosis. Through pharmacologic and nonpharmacologic interventions, pharmacists can be integral in the prevention and treatment of osteoporosis and its related fractures. This panel discussion will center on updates to the 2020 AACE/ACE guidelines for osteoporosis, as well as advances in treatment options and the role of pharmacists in supporting screening recommendations for patients to identify fracture risk. Indications, dosing, and clinical trial information for select available and emerging oral and parenteral therapies for osteoporosis will be discussed. Expert panelists will share tips to improve communication with patients about the initiation of therapy and counseling points to educate patients on the importance of maintaining a bone-healthy lifestyle and preventing the development of fractures related to osteoporosis. This program features a patient-perspective interview that will highlight the experience and challenges of a patient living with osteoporosis.,Educational Objectives:,At the completion of this activity, participants will be able to:,• Explain specific risk factors for fracture and the clinical, economic, and quality-of-life burden of osteoporosis,• Analyze updated AACE/ACE guidelines for the classification of fracture risk and recommendations for drug therapy,• Examine new and emerging therapies for osteoporosis, including mechanism of action, administration, safety and efficacy data, real-world evidence, and comparison studies,• Identify the role of the pharmacist in optimizing care for patients with osteoporosis, including appropriate counseling, the management of adverse effects, and monitoring